Is BioMarin Pharmaceutical (BMRN) Pricing Match Recent Share Rebound And DCF Upside Potential [Yahoo! Finance]
BioMarin Pharmaceutical Inc. (BMRN)
Last biomarin pharmaceutical inc. earnings: 4/29 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.biomarin.com
Company Research
Source: Yahoo! Finance
If you are wondering whether BioMarin Pharmaceutical's current share price lines up with its underlying worth, this article walks through what the numbers are really saying about value. The stock last closed at US$62.62, with returns of 4.5% over the past week and 11.4% over the past month, compared with a 5.3% return year to date and a 12.0% decline over the past year, alongside 37.1% and 19.6% declines over the past 3 and 5 years. Recent coverage of BioMarin Pharmaceutical has focused on its position in rare disease treatments and how the market is weighing its long term pipeline potential against execution risks. This context helps explain why the share price has seen short term strength while longer term returns remain weaker. Right now, BioMarin Pharmaceutical scores 2 out of 6 on our valuation checks , which suggests some measures point to undervaluation while others do not. We will look at what each approach is capturing, before finishing with a broader way to think abou
Show less
Read more
Impact Snapshot
Event Time:
BMRN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BMRN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BMRN alerts
High impacting BioMarin Pharmaceutical Inc. news events
Weekly update
A roundup of the hottest topics
BMRN
News
- BioMarin Pharmaceutical Inc. (BMRN) Presents at TD Cowen 46th Annual Health Care Conference Transcript [Seeking Alpha]Seeking Alpha
- BioMarin Pharmaceutical (BMRN) had its "overweight" rating reaffirmed by Barclays PLC.MarketBeat
- BioMarin Pharmaceutical (BMRN) was given a new $105.00 price target by Loop Capital.MarketBeat
- A Look At BioMarin (BMRN) Valuation After Recent Share Price Rebound [Yahoo! Finance]Yahoo! Finance
- Spruce Biosciences Touts MPS IIIB Data, Targets Q4 BLA Submission at Oppenheimer Conference [Yahoo! Finance]Yahoo! Finance
BMRN
Earnings
- 2/23/26 - Beat
BMRN
Sec Filings
- 2/26/26 - Form 4
- 2/26/26 - Form 4
- 2/26/26 - Form 4
- BMRN's page on the SEC website